| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3c7b245a3e015d932674c89f34efb39 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C225-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-06 |
| filingDate |
2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7982433363a678c2f66d56c1669e43 |
| publicationDate |
2022-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022371985-A1 |
| titleOfInvention |
Polymorphic compounds and uses thereof |
| abstract |
The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723890-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679090-B2 |
| priorityDate |
2018-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |